Cerebrospinal fluid dopa-decarboxylase is a biomarker of dopaminergic dysfunction
CSF DDC reflects nigrostriatal dopaminergic dysfunction, representing a potential quantitative biochemical alternative to DaT-SPECT that might be readily implemented via automated immunoassays.